I am an active professional 70 year old and was recommended for partial ablation HIFU treatment at UCLH in Feb.22 following escalation AS under G3+3 to more aggressive 3+4 but still contained within the gland (T2c).
At the time the UCLH consultant said the procedure is well tolerated with a failure rate of 15% but further HIFU treatment could be undertaken if required. By Autumn 2022 the PSA was rising faster than it should following HIFU and whole gland treatment was recommended, either RT or sRALP (salvage robotic-assisted radical prostatectomy) as the cancer had not only progressed but was now bilateral (on both sides). I initially favoured surgery but was told to my shock that because I had the HIFU treatment they would need to remove all my nerves which were now 'tethered' to the gland by the HIFU treatment on the left side. The right side had cancer but they said those nerves would have to go as well as part of the surgery they call salvage Prostatectomy. This would remove all my erectile function. I was not informed of this before I agreed to HIFU as recommended by NICE guidance 2005 which states"the man understands what is involved, and that its not clear how the procedure affects mens's day-to-day lives or how long the effects last".
I dug a little and was appalled to learn that this is a novel procedure adopted in the UK but banned in the US and Europe outside clinical trials. (BJUI Journal 2023,131:20-31 dol: 10.1111/bju.15883 states "The literature suggests that the oncological effectiveness of FT (focal treatment) remains unproven due to lack of reliable comparative data etc."
Suny Medical University Hospital, New York states the actual effect on the anatomy of HIFU cannot be predicted" and "the failure rate of partial gland ablation ranges between 35% and 42% with approximately 14% in-field recurrence." (Journal European Urology Focus 8 (2022) 1192-1197). More worrying still, a study by UCLH themselves with Guys,Kings and Imperial states "Specifically, we identified that men experiencing an infield recurrence [like me] had almost four times the risk of developing biochemical failure after sRALP, independent of margin status, Gleason grade group, PSA, or pT stage. This suggests that those experiencing infield recurrence might have a more aggressive cancer phenotype ...One hypothesis for this finding is that an initial incomplete ablation might result in the development of "ablation resistant" clones that repopulate the ablation field and metastasise locoregionally. The biological mechanism of this phenomenon is yet to be described...."
(European Urology 76 (2019) 27-30)
So not only is the effect of HIFU on the human anatomy unknown and the procedure not approved in US and EU, here there is a suggestion by UCLH themselves that zapping the prostate gland with high frequency energy which, it is well understood causes fibrosis with consequent reduced blood flow, could be encouraging more aggressive cancer cells to repopulate less aggressive cancer cells killed by the HIFU treatment!!
I am totally appalled. HIFU is a dangerous toy which should not be approved outside clinical trials by NICE.
I was not offered nerve spare sRARP by UCLH which they said they discontinued after a trial in 2018. So I have had to go private at have had a successful 100% nerve spare sRARP at Guys at a considerable cost (c£22k). I await the post op histology but its looking good so far.
I would have and would now urge anyone considering HIFU to go straight to surgery.